 Vyga G. Kaufmann
| Title | Research Associate |
|---|
| Institution | University of Colorado Boulder |
|---|
| Department | Cognitive Sci Institute-Admin |
|---|
|
|
|
| Title | Assistant Teaching Professor |
|---|
| Institution | University of Colorado Boulder |
|---|
| Department | Psych-Psychology |
|---|
|
|
|---|
|
 Bibliographic
-
Kaufmann VG, O'Farrell TJ, Murphy CM, Murphy MM, Muchowski P. Alcohol consumption and partner violence among women entering substance use disorder treatment. Psychol Addict Behav. 2014 Jun; 28(2):313-21. PMID: 24955661.
-
Lerman C, Jepson C, Wileyto EP, Epstein LH, Rukstalis M, Patterson F, Kaufmann V, Restine S, Hawk L, Niaura R, Berrettini W. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Neuropsychopharmacology. 2006 Jan; 31(1):231-42. PMID: 16123753.
-
Strasser AA, Kaufmann V, Jepson C, Perkins KA, Pickworth WB, Wileyto EP, Rukstalis M, Audrain-McGovern J, Lerman C. Effects of different nicotine replacement therapies on postcessation psychological responses. Addict Behav. 2005 Jan; 30(1):9-17. PMID: 15561445.
-
Lerman C, Kaufmann V, Rukstalis M, Patterson F, Perkins K, Audrain-McGovern J, Benowitz N. Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial. Ann Intern Med. 2004 Mar 16; 140(6):426-33. PMID: 15023708.
-
Patterson F, Lerman C, Kaufmann VG, Neuner GA, Audrain-McGovern J. Cigarette smoking practices among American college students: review and future directions. J Am Coll Health. 2004 Mar-Apr; 52(5):203-10. PMID: 15029942.
-
Collins BN, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Kaufmann V, Pinto A, Hawk L, Niaura R, Epstein LH, Lerman C. Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling. Nicotine Tob Res. 2004 Feb; 6(1):27-37. PMID: 14982685.
-
Lerman C, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Restine S, Shields PG, Kaufmann V, Redden D, Benowitz N, Berrettini WH. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial. Pharmacogenomics J. 2004; 4(3):184-92. PMID: 15007373.
-
Kaufmann V, Jepson C, Rukstalis M, Perkins K, Audrain-McGovern J, Lerman C. Subjective effects of an initial dose of nicotine nasal spray predict treatment outcome. Psychopharmacology (Berl). 2004 Mar; 172(3):271-6. PMID: 14647969.
-
Patterson F, Jepson C, Kaufmann V, Rukstalis M, Audrain-McGovern J, Kucharski S, Lerman C. Predictors of attendance in a randomized clinical trial of nicotine replacement therapy with behavioral counseling. Drug Alcohol Depend. 2003 Nov 24; 72(2):123-31. PMID: 14636967.
-
Kaufmann V, Lerman C. Genes, smoking, and treatment response. Am J Health Syst Pharm. 2003 Sep 15; 60(18):1911. PMID: 14521049.
-
Patterson F, Benowitz N, Shields P, Kaufmann V, Jepson C, Wileyto P, Kucharski S, Lerman C. Individual differences in nicotine intake per cigarette. Cancer Epidemiol Biomarkers Prev. 2003 May; 12(5):468-71. PMID: 12750245.
-
Lerman C, Roth D, Kaufmann V, Audrain J, Hawk L, Liu A, Niaura R, Epstein L. Mediating mechanisms for the impact of bupropion in smoking cessation treatment. Drug Alcohol Depend. 2002 Jul 01; 67(2):219-23. PMID: 12095672.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
| Year | Publications |
|---|
| 2002 | 1 | | 2003 | 4 | | 2004 | 4 | | 2005 | 1 | | 2006 | 1 | | 2014 | 1 |
To return to the timeline, click here.
|
Kaufmann's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|